Protalix BioTherapeutics, Inc. (PLX) Insider Trading & SEC Filings

Updated Jul 16, 2026 · Last SEC filing 2025-11-19

Protalix BioTherapeutics, Inc. (PLX) — no SEC Form 4 insider filings recorded in the last 90 days. 3 Form 8-K material event filings were reported by PLX in the last 90 days. InsiderAlpha tracks every PLX SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.

About Protalix BioTherapeutics, Inc. (PLX)

SIC classification	Biological Products, (No Diagnostic Substances) (SIC 2836)
SEC CIK	0001006281

90-Day SEC Filing Activity

Form 8-K filings (90d)	3
Latest Form 4 filing	2025-11-19

Recent PLX Insider Transactions (Form 4)

Date	Insider	Role	Transaction	Shares	Price	Value	Filing
2025-09-03	Forster Eliot	Insider	A — Grant or award	7.5K	—	—	SEC
2025-09-03	Bar-Shalev Amos	Insider	A — Grant or award	7.5K	—	—	SEC
2025-09-03	Boudes Pol F	Insider	A — Grant or award	7.5K	—	—	SEC
2025-09-03	Melincoff Gwen A	Insider	A — Grant or award	7.5K	—	—	SEC
2025-09-03	Ben Zvi Shmuel	Insider	A — Grant or award	7.5K	—	—	SEC
2025-09-03	Schwartz Aharon	Insider	A — Grant or award	7.5K	—	—	SEC
2025-09-03	Elze Christian	Insider	A — Grant or award	7.5K	—	—	SEC
2025-09-03	Bashan Dror	PRESIDENT AND CEO	A — Grant or award	195.0K	—	—	SEC
2025-09-03	Naos Yaron	Sr. VP, Operations	A — Grant or award	25.0K	—	—	SEC
2025-06-10	Schwartz Aharon	Insider	P — Open-market purchase	129.0K	$1.60	$206K	SEC

All transactions sourced from SEC EDGAR Form 4 filings for Protalix BioTherapeutics, Inc. (PLX). Updated in real time as new filings are submitted to the SEC.

Recent PLX Form 8-K Material Events

2026-06-25 — Item 5.07, 9.01 [SEC]
2026-05-21 — Item 7.01, 9.01 [SEC]
2026-05-13 — Item 2.02, 9.01 [SEC]
2026-03-18 — Item 2.02, 9.01 · Earnings · neutral [SEC]
Protalix BioTherapeutics announced its financial results for fiscal year 2025 and provided a business and clinical update on March 18, 2026. The filing contains standard annual results reporting without explicit beat/miss language or forward guidance changes.
2026-03-09 — Item 8.01, 9.01 · Clinical · positive [SEC]
The European Commission approved a new dosing regimen (2 mg/kg every-4-weeks) for Elfabrio® (pegunigalsidase alfa) in adults with Fabry disease who are stable on enzyme replacement therapy. This regulatory approval expands the commercial flexibility and treatment options for the

Recent Insider Filings

2025-11-19 — Bar-Shalev Amos (Insider)
2025-09-03 — Boudes Pol F (Insider)
2025-09-03 — Melincoff Gwen A (Insider)
2025-09-03 — Ben Zvi Shmuel (Insider)
2025-09-03 — Bar-Shalev Amos (Insider)

Form 4 Transaction Code Reference

SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in PLX insider filings:

P	Open-market purchase by the insider
S	Open-market sale by the insider
A	Grant, award, or other acquisition from the issuer
M	Exercise or conversion of derivative security (e.g. options)
F	Payment of exercise price or tax liability via share withholding
G	Bona-fide gift of securities
D	Disposition to the issuer (e.g. share buyback participation)
J	Other acquisition or disposition
X	Exercise of in-the-money or at-the-money derivative security
C	Conversion of derivative security
V	Transaction voluntarily reported earlier than required

PLX Insider Trading — FAQ

What is the latest insider trade for PLX?: Protalix BioTherapeutics, Inc. (PLX) had 0 insider filings in the last 90 days, with the most recent on 2025-11-19. InsiderAlpha tracks every Form 4, 10-K, 10-Q, and 8-K filing in real time.
How many insiders are buying PLX stock?: 0 insider purchases of PLX were filed in the last 90 days.
How many insiders are selling PLX stock?: 0 insider sales of PLX were filed in the last 90 days.
Where can I see PLX SEC filings (Form 4, 10-K, 10-Q, 8-K)?: InsiderAlpha aggregates every PLX SEC filing — Form 4 insider transactions, 10-K and 10-Q quarterly reports, and 8-K material event disclosures — in one timeline.

Related Companies — Recent Insider Activity

Learn More

Open the live PLX dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.